Webinar
Covid 19 and Clinical Trials: Support Risk Mitigation and Recovery Plans With Data and Analytics
Recorded on: May 19, 2020 | Acorn AI

This webinar will address the impact of Covid 19 on clinical trials and highlight how industry-wide trial metrics and analytics can be used to support situation tracking, impact forecasting, and recovery planning. Register now.

Webinar
Impacts of Continuous Manufacturing in Development
Recorded On: May 13, 2020 | Thermo Fisher Scientific

Continuous manufacturing represents a new paradigm in the development and manufacturing of oral solid dose products. In a continuous manufacturing process, products are produced via an integrated series of modular unit operations. The raw materials are fed into the process and converted into the oral solid dose product at a continuous rate without interruption. As a result, this process has greater control, no scale up and can provide multiple benefits in both development and commercial manufacturing. Register Today!

Webinar
Implications of Historical Control Studies for Rare Disease Products
Recorded on May 13, 2020 | Rho

Development programs in rare diseases are becoming a major focus for small biotech and pharmaceutical companies. A crucial consideration is the choice of control group used to assess efficacy. Through recent case studies, we will discuss factors to consider, appropriate analysis, and the critical role that externally controlled studies play in supporting marketing applications for orphan/rare disease products. Register now.

Webinar
Coronavirus Virtual Series: Where are we now?
Virtual Event | Available On-Demand | FiercePharma and FierceHealthcare

The editorial teams of FiercePharma and FierceHealthcare bring you another week of live virtual updates and expert panels discussing the coronavirus. We’ll do a status update about our progress so far and what challenges remain ahead. Watch the sessions on-demand.

eBook
Direct-to-Patient Supply for Recruitment and Retention of Study Patients
Catalent

To better understand sponsors’ perspectives on DTP and interest in using it in their studies, Catalent and FiercePharma surveyed 234 individuals involved in clinical supply and operations. Download this infographic to learn more about the survey results.

Webinar
Why MedTech Companies Should Have a Data Strategy for Value-Based Care
Wednesday, May 6, 2020 | 12pm ET / 9am PT | InterSystems

With the right data, analytic strategy, and program governance, forward-leaning companies can make an impact. Learn about Medtronic’s value-based healthcare strategy as a means to create benefits for providers, payers, and most importantly patients. Register now. 

Webinar
Fast-start-up of vaccine studies for COVID-19: Tips and Considerations to do it Right
Recorded On: May 6, 2020 | Parexel

With the evolving situation of COVID-19 companies are rushing to get new vaccines to patients and bring this outbreak to a close. Join Parexel’s experts as they draw on vaccine experience and learnings to share tips and considerations for the fast start-up of vaccine trials. Save your spot today!

Webinar
Novel Trial Design Strategies with a Personalized ctDNA Assay
Recorded On: May 5, 2020 | Natera

Discover the latest advantages of using a personalized, tumor-informed circulating tumor DNA (ctDNA) test to design oncology clinical trials in solid tumors.  Learn how Signatera, a breakthrough technology, can be applied in early stage and late stage cancer trials, potentially enriching for patients most likely to respond to therapy, accelerating time to trial readout, or identifying early relapsers. Register to watch this recording!

Paid Marketplace
Perspective: the patient edition
Blue Latitude Health

In this issue of ‘Patient Perspective’ we show you many ways the healthcare industry can place a greater emphasis on patient-centricity, and how pharmaceutical companies are developing products and services that better serve unmet patient needs.  Download the magazine.

Webinar
Coronavirus Virtual Series
Recorded on: March 30 - April 2, 2020 | FierceHealthcare and FiercePharma

FiercePharma and FierceHealthcare bring you a week of virtual updates and expert panels discussing the coronavirus. We're assembling a series of experts to discuss industry’s role in preparing for a pandemic and what steps can be taken to mitigate risk while dealing with the outbreak. Register for on-demand sessions now.

Webinar
[Webinar] Maintaining Momentum: Applying Recent Regulatory Guidance in the Midst of the Coronavirus
Recorded On: April 30, 2020 | Cato Research

A panel of CATO SMS experts will review the key issues contained in the emerging Agency Guidance and offer thoughts on what changes and options for sponsors may be seen in the coming months. Click here to register for this webinar.

Whitepaper
The great data transition: Making the move from claims to EHR data
Optum

As the pressure to prove the value of existing and new therapies increases, it’s critical to leverage more comprehensive data assets. This whitepaper addresses how the immediacy of EHR data availability can be significantly impactful, particularly as the health care system works to address COVID-19.

Webinar
Declutter the Data in your Clinical Trial: Mitigate Risk Before it Becomes an Issue
Recorded on: April 29, 2020 | Medidata

Today more than ever the ability to process real-time data from disparate sources is critical to patient safety and data quality. Join us for a discussion and Q&A on how to find errors, trends, and anomalies in data to mitigate risk effectively.

Register Now >>>

Webinar
Successful Clinical Trials in the Era of Genetics-based Medicine
Recorded on: April 28, 2020 | InformedDNA

In this webinar, we'll explore how to address and overcome challenges in genetics-based clinical trials, using real-life case studies. InformedDNA is the authority on the appropriate use of genetic testing and the leading telemedicine provider of clinical genetics services. 

Who should attend? Anyone involved in designing or operating clinical trials for rare disease therapies. Register now.

Webinar
Parexel’s learnings from China: Clinical studies in a pandemic-transformed world
Recorded on: April 23, 2020 | Parexel

Join Parexel experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in China. Our panel will provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’ and what longer-term changes are likely to occur because of the pandemic – and the opportunities and challenges these changes present. Register Now.

Webinar
Getting Ahead of the Curve: Insights from COVID-19’s Frontlines
April 23, 2020 1 p.m. EST / 10 a.m. PST | InCrowd

How is COVID-19 impacting HCPs and patients? Join Daniel S. Fitzgerald, InCrowd CEO & President and Philip Moyer, InCrowd VP of Crowd Operations, to review the key findings. Register now.

Webinar
Leads Discovered: Accelerating Drug Discovery with Novel Tools for Structure & Sequence Activity Relationship Analysis
Recorded On: April 22, 2020 | PerkinElmer

As Biologics and sequence-based therapeutics become more pervasive, a new set of Sequence-Activity-Relationship tools are gaining importance in drug discovery. This webcast will showcase how AbbVie has been working with PerkinElmer solutions that extend their SAR analysis capabilities to include both small molecules and biologics in a single extensible platform that promises to expedite the lead discovery process. Click here to register.

Webinar
Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey
Recorded on: April 21, 2020 | Amazon Web Services

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional (e.g comparative effectiveness) and advanced analytics (e.g. machine learning , NLP) for day to day evidence generation (RWE). Register now.

Webinar
Drug Product Advancement – A Path Through Development by Powder in Capsule Approach
April 14, 2020 11 a.m. EST / 8 a.m. PST | Lonza

Using micro-dosing technology and powder-in-capsule (PIC) or bottle (PIB) approaches, biopharmaceutical companies have the ability to increase speed to clinic, quickly assess their candidate compounds, and remain cost-conscious in early stage development.  Attendees working with an oral solid dosage development and manufacturing will benefit from this educational webinar.  This webinar will also be informative to attendees with responsibilities for rapid first-in-human studies with oral solid drug product. Register now.

Research
Precision Analytics for Product Launch and Growth
Clarify Health

Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. 

Webinar
Clinical Trial Data meets the Real World: Bridging the Experimental and Post-Launch Worlds
Recorded on: April 2, 2020 | Acorn AI by Medidata

This webinar will address key considerations and best practices when combining clinical trial data with real world data to power big data analytics. Register now for the on-demand version.

Whitepaper
2020 State of the Life Sciences Industry: Big Pharma Is Getting Bigger
LexisNexis

A search for new manufacturing partners comes with an acute need to vet these new entities against multiple global watchlists to prevent  fraud, money-laundering, or corruption risks. Download the 2020 State of Life Sciences infographic for the current industry snapshot. Find out where the main manufacturing hubs are and the level of corruption of the countries in which they are located.

 

Survey
Data Analytics in Life Sciences: 2020 State of the Industry Survey
FierceMarkets Custom Publishing

The life sciences industry has always relied upon empirical data and analytics to inform product development activities and commercial strategies. The goal of this research is understand the drivers, benefits and barriers to scaling analytics across all facets of a life sciences organization’s operations.

Begin the survey for a chance to be one of 50 qualified respondents to receive a $5 Amazon gift card.

Webinar
Before GLP: The Value of Robust Exploratory Toxicology Prior to Pivotal GLP Studies
Recorded on: March 26, 2020 | Frontage Laboratories

The webinar on March 26 is “Before GLP: The value of robust exploratory toxicology prior to pivotal GLP studies.”  Mr. Ryan will share experiences and stories, as well as suggestions for how to set up a successful IND approach.  We hope you will find our discussion insightful and help you avoid unexpected surprises in your IND-directed studies. Register to save your spot today!

Webinar
Managing the Risks of Implementing E6R2
Recorded on: March 25, 2020 | Rho

Successful implementation of RBQM is a challenge many in our industry are facing. To understand what it is and how it impacts the management of your clinical trial, this webinar will address what exactly E6R2 is. We will use Rho as a case study for designing and implementing a strategy, discuss common misconceptions, and review lessons Rho has learned through implementation of RBQM. Click here to register for this webinar today!

Webinar
Accelerate Clinical Operations Across Sponsors, CROs and Partners With a Best-of-Breed Partner Like Box
Aired on: March 24, 2020 | Box

Learn how Box is a critical force multiplier in the Best-of-Breed application stack with partners like Nintex, DocuSign and Slack in supporting clinical operations for both regulated and non-regulated content. Register now.

Webinar
Thermo Fisher Scientific Invests $800 Million to Help Biopharma and Pharma Companies Accelerate Commercialization and Bring Medicines to Patients Faster
Recorded on March 23, 2020 | Patheon

Join Thermo Fisher Scientific for a live webcast on its $800 million investments in its biologics, cell and gene therapy, and drug product capabilities to help biopharma and pharma companies of all sizes accelerate commercialization and bring medicines to patients faster.

Webinar
Use Serialization Data to Maximize Performance and Minimize Risks
March 18, 2020 11 a.m. EST / 9 a.m. PST | Systech

Serialized products generate a wealth of data as they move through the supply chain. What if you could access and analyze this data to gain operational visibility and powerful business insight? It’s time to put your serialization investment to work for you. Learn how in this webinar.

Paid Marketplace
Capsugel® Quality
Capsugel

Not all capsules are created equal …

Capsugel® has a global network of manufacturing facilities, which are routinely inspected by regulatory authorities, customers and our own internal audit teams. We work diligently every day to ensure the strictest industry standards for our products.  Learn more.

Survey
Artificial Intelligence in the Pharma Industry
OpenText

Obtaining feedback from Life Sciences organizations are key in the delivery of actionable insights that our target customers come to expect. Our goal is to assess how far the adoption of AI technology has come in Life Sciences. Complete the survey for a chance to be one of 50 qualified respondents to receive a $5 Amazon gift card.

Webinar
Translational Modeling Strategies to Predict Clinical Doses for CD3 Bispecific Molecules
Recorded on: March 12, 2020 | Applied BioMath

Learn how a Quantitative Systems Pharmacology (QSP) model and translational framework described for CD3 bi-specific molecules provides a holistic solution for quantitative decision making throughout the drug discovery and development process. Register now.

Whitepaper
Measure the Right Things at the Right Time: Using A Metric Maturity Model to Optimize Performance Measurement
WCG Metrics Champion Consortium

How does your organization measure clinical trial performance? Does it measure the right things? Does it measure them effectively? Ineffective measurement could mean wasting both time and money. This whitepaper showcases a custom-built Metric Maturity Model that helps illustrate and define the process for measuring the right things the right way.  Download the whitepaper

Whitepaper
Manufacturing Cytotoxic and Non-Cytotoxic
Baxter

When different drug products are produced in shared facilities, potential for cross-contamination needs to be addressed.  Outsourcing to a CMO with experience in multiproduct facilities can be an option. Download the whitepaper.

Webinar
Accelerating Approval for Cell and Gene Therapies
Recorded on: February 27, 2020 | Cardinal Health

Developers of cell and gene therapies can run into complex clinical and regulatory hurdles when bringing treatments to patients. Join experts from Cardinal Health Regulatory Sciences to explore critical factors that can help reduce the risk of failure and increase speed to market. Register for this webinar today!

Webinar
Tufts-eClinical Solutions Data & Analytics Survey Results
Recorded on: February 26, 2020 | eClinical Solutions

Key findings from the 2019 Life Sciences Data & Analytics Survey conducted by the Tufts Center for the Study of Drug Development will be unveiled during this live webinar led by industry expert and study lead, Ken Getz, Director of Sponsored Programs and Associate Professor. Watch On Demand Now!

Whitepaper
Navigating HUB Design in 2020: Insource vs. Outsource vs. Hybrid
Archbow Consulting

Current industry trends are creating a shift in how manufacturers are approaching their HUB programs. Download this whitepaper to explore a variety of factors to consider when choosing between insourced, outsourced, and hybrid HUB models.

Webinar
Understanding the New MDR Article 117 and its Impact on Combination Product Applicants and Medical Device Constituent Part Supplier
February 13, 2020 11 a.m. EST / 8 a.m. PST | West Pharmaceutical Services, Inc.

Understanding the medical device design and how it forms integral and non-integral drug device combinations (DDC’s)  is critical to navigate the new European regulatory landscape.Examples of these expectations will be presented to outline the overall impact of Article 117 and additional elements of the MDR 2017/745 pertaining to combination drug products as regulated within the European community.  Register now.

Webinar
InCrowd’s 2020 Healthcare Predictions
Recorded on: February 11, 2020 | InCrowd

How will 2020 change US healthcare? InCrowd’s physicians weigh in on what the new year will bring. Join Diane Hayes, PhD, InCrowd Co-Founder and Board Member and Daniel S. Fitzgerald, InCrowd CEO and President, for InCrowd’s 2020 Healthcare Predictions Webinar. Register Now!

Webinar
Model-Based Approach to Design Bi-Specific Modalities in Early Discovery
Recorded on: February 4, 2020 | Applied BioMath

Learn how we used a tiered model-based approach of a bi-specific antibody to appropriately cover multiple antigen pairs to help teams with informed antibody design, prioritization of experiments, and triaging of challenging antigen pairs.  Register today.

Webinar
5 Ways to Make Monitoring More Efficient
Recorded on January 30, 2020 | Veeva

This new year, take a fresh look at your monitoring processes and learn how to improve efficiency across the entire monitoring lifecycle. Register for the webinar here.

Webinar
Cartridge Based Drug Delivery…Evolving Technologies Designed With the Patient in Mind.
Recorded on January 28, 2020 | West Pharmaceutical Services, Inc.

The focus of this webinar will be on the design and process approach for next generation large volume delivery systems for prefilled cartridge delivery, as well as on providing an overview of key critical product requirements, such as compatibility with sensitive drug products, system functionality, and fill-finish implementation. Register now.

Webinar
Perceptions, Myths & New Thinking on Direct-to-Patient Clinical Supply
Recorded on January 23, 2020 | Catalent

This webinar reveals results from a recent industry survey that sought to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. Register now to learn more.

Webinar
The Art of Recognizing Clinical Supply Risk Factors and Applying Proactive Measures Avoid Study Delays and Disruptions
Recorded on January 14, 2020 | Catalent

Are there certain types of clinical sponsors and studies that are at greater risk of experiencing supply challenges? This webinar will explore aspects of the study protocol that can directly influence clinical supply strategy and how sponsors can proactively understand and address clinical supply-related risks. Register now.

Webinar
Transportation Solutions for Cell & Gene Therapy Supply Chains
Recorded on December 17, 2019 | Thermo Fisher Scientific

From the basics such as service level expectations for couriers versus integrators, to how to evaluate domestic and international lanes, and finally – how to balance risk and cost, this webinar will help you understand how to start tackling your clinical supply chain. Register now.

Webinar
Digital Medicine 101
Recorded on December 12, 2019 | Amazon Web Services

Join us as an interdisciplinary group of experts from the Digital Medicine Society (DiMe) provide a brief introduction to core concepts and terms that define digital medicine, along with practical tips for implementation and case examples. 

Webinar
Planning a Rapid Commercial Market Launch for Your Biologic
Recorded on December 4, 2019 | Catalent

In this webinar, AstraZeneca and Catalent Biologics experts will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients. Register now.

Webinar
How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
Recorded on December 3, 2019 | Veeva

Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.  Learn how to reap the rewards of a straightforward build and a modern EDC during this webinar. Register now.

Whitepaper
Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence
Truveris

It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers. Download this whitepaper now to learn more about prescription drug price transparency and its role in creating affordability, accessibility, and accountability.

Webinar
Driving Patient Innovation Through Software as a Medical Device
Recorded on November 21, 2019 | Accenture

Accenture experts will explore the emergence of SaMD as a new class of medical device and discuss the potential challenges that biopharma companies face in the development of these solutions. Register for this webinar now.

Webinar
Striving for Zero in Quality & Manufacturing
Recorded on November 19, 2019 | OpenText

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. At the same time, they must meet GxP requirements, update antiquated systems and processes, and address the demands of an increasingly tech savvy workforce. Register now to learn more about the role that content management plays in pharmaceutical manufacturing.